DBV Technologies (DBVT) Retained Earnings (2019 - 2026)
DBV Technologies (DBVT) reported Retained Earnings of -$440.7 million for Q1 2026, down 42638.61% year-over-year from N/an in Q1 2025, and down 88240.0% quarter-over-quarter from $500000.0 in Q4 2025.
DBV Technologies (DBVT) Retained Earnings (2019 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 8 years of Retained Earnings data on file, last reported at -$440.7 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$440.7 million, down 42638.61% year-over-year; the trailing twelve-month figure through Mar 2026 was -$440.7 million (down 42638.61% YoY), and the FY2025 annual result was $500000.0, down 44.75% from the prior year.
- Retained Earnings retreated to -$440.7 million in Q1 2026 per DBVT's latest filing, from $500000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $1.0 million in Q1 2025 and troughed at -$440.7 million in Q1 2026.
- A 5-year average of -$139.5 million and a median of $500000.0 in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 69077.19% in 2022, then jumped 100.39% in 2025.
- A 5-year view of Retained Earnings shows it stood at $781000.0 in 2022, then slipped by 4.99% to $742000.0 in 2023, then rose by 21.97% to $905000.0 in 2024, then sank by 44.75% to $500000.0 in 2025, then tumbled by 88240.0% to -$440.7 million in 2026.
- Business Quant data shows DBVT's Retained Earnings at -$440.7 million in Q1 2026, $500000.0 in Q4 2025, and -$348.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | -440.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -440.70 Mn |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | -348.30 Mn |
| Jun 30, 2025 | -315.14 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 905,000.00 |
| Sep 30, 2024 | 709,000.00 |
| Jun 30, 2024 | -232.89 Mn |
| Mar 31, 2024 | -266.21 Mn |
| Dec 31, 2023 | 742,000.00 |
| Sep 30, 2023 | 761,000.00 |
| Jun 30, 2023 | 687,000.00 |
| Mar 31, 2023 | -280.14 Mn |
| Dec 31, 2022 | 781,000.00 |
| Sep 30, 2022 | -220.34 Mn |
| Jun 30, 2022 | 743,000.00 |
| Mar 31, 2022 | -275.22 Mn |
| Dec 31, 2021 | -258.53 Mn |
| Sep 30, 2021 | 474,000.00 |
| Jun 30, 2021 | 446,000.00 |